Commercializing successful biomedical technologies: Basic principles for the development of drugs, diagnostics and devices

Commercializing Successful Biomedical Technologies: Basic Principles for the Development of Drugs, Diagnostics and Devices

Volumn 9780521870986, Issue , 2008, Pages 1-335

  Mehta, Shreefal S ^a  

^a Business and Corporate Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CURRICULA; DIAGNOSIS; PRODUCT DEVELOPMENT; STUDENTS;

BASIC PRINCIPLES; BIOMEDICAL TECHNOLOGIES; BIOTECHNOLOGY INDUSTRY; CAPSTONE DESIGN COURSE; COMMERCIAL PRODUCTS; MARKET ANALYSIS; MEDICAL PRODUCTS; PRODUCT DESIGN AND DEVELOPMENT;

PRODUCT DESIGN;

EID: 84924699119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511791345     Document Type: Book

References (128)

1. Bronzino, J. (ed.). Biomedical Engineering Handbook, CRC Press, 3rd edn., 2006.
2. Burns, L. (ed.). The Health Care Value Chain, Jossey-Bass, 2002.
3. Burns, L. (ed.). The Business of Healthcare Innovation, Cambridge University Press, 2005.
4. Chiesa, V. and Chiaroni, D. Industrial Clusters in Biotechnology, Imperial College Press, 2004.
5. Collins, S. W. The Race to Commercialize Biotechnology, Routledge, 2004.
6. DeVol, R., Wong, P., Ki, J., Bedroussian, A., and Koepp, R. America’s Biotech and Life Science Clusters, Milken Institute, 2004. Available at www.milkeninstitute.org/pdf/biotech_clusters.pdf.
7. DiMasi, J. A., Hansen, R. W., and Grabowski, H. G. The price of innovation: new estimates of drug development costs, Journal of Health Economics, 22, 151–185, 2003.
8. Ernst and Young. Beyond Borders: Global Biotechnology Report, Ernst and Young, 2006.
9. Estrin, N. F. The Medical Device Industry: Science, Technology, and Regulation in a Competitive Environment, Marcel Dekker, 1990.
10. Hartford, C. T. The Worldwide Market for In Vitro Diagnostic Tests, Kalorama Information, 2002.
11. Kayser, O. and Müller, R.H. (eds.). Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications, John Wiley & Sons, 2004.
12. McKelvey, M. D., Rickne, A., and Laage-Hellman, J. (eds.). The Economic Dynamics of Modern Biotechnology, Edward Elgar Publishing, 2004.
13. Moore, J. E. and Zouridakis, G. (eds.). Biomedical Technology and Devices Handbook, CRC Press, 2004.
14. Porter, M. Competitive Advantage: Creating and Sustaining Superior Performance, The Free Press, 1985.
15. Ratledge, C. and Kristiansen, B. (eds.). Basic Biotechnology, Cambridge University Press, 2nd edn., 2001.
16. Roco, M. C. and Bainbridge, W. S. (eds.). Converging Technologies for Improving Human Performance, Springer, 2004.
17. Sasson, A. Medical Biotechnology, United Nations University Press, 2006.
18. www.bio.org – Biotechnology Industry Organization
19. www.phrma.org – Pharmaceutical Research and Manufacturers Association
20. www.medicaldevices.org – Medical Device Manufacturers Association (mostly small to midsized device and diagnostics companies)
21. www.advamed.org – Advanced Medical Technology Association (large medical device manufacturers’ advocacy and lobbying association)
22. www.devicelink.com – Medical Device Link (trade publication)
23. www.biomaterials.org – Society for Biomaterials
24. Cohen, W. A. The Marketing Plan, 2nd edn., Wiley Press, 1998.
25. Kalorama Information. The World-wide Market for In Vitro Diagnostic Tests, 4th edn., Kalorama Information, 2004. Available from www.marketresearch.com.
26. Standard and Poor’s. Medical Device Industry Survey, Standard and Poor’s, 2004.
27. Ulrich, K. T. and Eppinger, S. D., Product Design and Development, 3rd edn., McGraw-Hill, Boston, MA, 2003. (Note – this book also has a practical section on working out client orcustomer needs through various steps of market research).
28. Weintraub, A. Biotech and the spoils of success, Business Week, August 13, 2001.
29. www.cdc.gov/nchs – The National Center for Health Statistics for information on disease incidence and prevalence in the USA
30. www.cdc.gov/nchs/about/major/hdasd/listpubs.htm – The National Hospital Discharge Survey gives detailed numbers of admissions for each disease and numbers of each major surgical procedure that is performed in the USA.
31. www.imshealth.com – Prescription drug sales information reports
32. http://rarediseases.about.com/– Orphan indications
33. www.wrongdiagnosis.com/– Symptoms, disease description, and epidemiology
34. www.hoovers.com – Hoover’s industry lists
35. Navigate from www.lib.rpi.edu home page by clicking through Home>Research assistance>Course web pages>Lally School – Resources webpage for market research
36. Breneman, L. University–industry collaborations: partners in research promoting productivity and economic growth, Research Management Review, 13(2), 2003.
37. Goldscheider, R. Licensing Law Handbook: The New Companion to Licensing Negotiations. St. Paul, MN: West Group, 2003.
38. Lerner, P. J. and Poltorak, A. I. Essentials of Intellectual Property, John Wiley & Sons, 2002.
39. Mowery, D. C., Nelson, R. R., Sampat, B. N., and Ziedonis, A. A. Ivory Tower and Industrial Innovation: University–Industry Technology Transfer Before and After the Bayh-Dole Act in the United States, Stanford Business Books, 2004.
40. Smith, G. V. and Parr, R. L. Intellectual Property: Valuation, Exploitation, and Infringement Damages, John Wiley & Sons, 2005.
41. US Department of Commerce. Patents and How to Get One: A Practical Handbook, Dover Publications, 2003.
42. Winslow, R. Will stent makers fight dentist’s patent tooth and nail? Wall Street Journal, January 26, p. B1, 2006.
43. www.uspto.gov – US patent and trademark office
44. www.wipo.org – WIPO
45. www.epo.org – European patent office
46. www.uspto.gov/main/trademarks.htm and www.ladas.com/Trademarks/tmprot.html – Trademark link
47. www.uspto.gov/web/offices/com/annual/2005/040201_patentperform.html – US PTO: patent processing times
48. www.patentbaristas.com
49. www.patentdocs.us
50. Block, Z. and MacMillan, I. C. Corporate Venturing: Creating New Businesses within the Firm, Harvard Business School Press, 1993.
51. Christensen, C. The Innovator’s Dilemma: The Revolutionary Book that Will Change the Way You Do Business, Harvard Business School Press, Reprint 2003.
52. Cooper, R. G. The new product process: a decision guide for managers. Journal of Marketing Management, 3, (3) 238–255, 1988.
53. DiMasi, J. A., Hansen, R. W., and Grabowski, H. G. The price of innovation: new estimates of drug development costs, Journal of Health Economics, 22, 151–185, 2003.
54. Fries, R. (ed.). Handbook of Medical Device Design, Marcel Dekker Press, 2001.
55. Gad, S. C. (ed.). Drug Discovery Handbook, Wiley-Interscience, 2005.
56. Galbraith, J. R., Matrix organization designs – how to combine functional and project forms, Business Horizons, 17, 1, 29–40, 1971.
57. Gray, C. F. and Larson, E. Project Management: The Managerial Process, McGraw-Hill/Irwin, 3rd edn., 2006.
58. Justiniano, J. and Gopalaswamy, V. Six Sigma for Medical Device Design, CRC Press, 2004.
59. Krogsgaard-Larsen, P, Liljefors, T, and Madsen, U (eds.). Textbook of Drug Design and Discovery, CRC Press, 3rd edn., 2002.
60. Larson, E. W. and Gobeli, D. H. Organizing for product development projects, Journal of Product Innovation Management, 5, 180–190, 1988.
61. Leifer, R., McDermott, C. M., O’Connor, G. C., et al.Radical Innovation: How Mature Companies can Outsmart Upstarts, Harvard Business School Press, 2000.
62. Lynn, G. S, Morone, J. G., and Paulson, A. S. Marketing and discontinuous innovation: the probe and learn process, California Management Review, 38(3), 8–37, 1996.
63. Metzler, R. Biomedical and Clinical Instrumentation: Fast Tracking from Concept through Production in a Regulated Environment. Interpharm Press, 1994.
64. Pisano, G. P. The Development Factory: Unlocking the Potential of Process Innovation, Harvard Business School Press, 1996.
65. Prentis, R. A., Lis, Y., and Walker, S. R. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985), British Journal of Clinical Pharmacology, 25, 387–396, 1988.
66. Project Management Institute, A Guide to the Project Management Body of Knowledge (PMBOK®), Project Management Institute, 3rd edn., 2004.
67. Sapienza, A. M. Creating Technology Strategies: How to Build Competitive Biomedical R&D, Wiley-Liss, 1997.
68. Whitmore, E. Development of FDA-Regulated Medical Products: Prescription Drugs, Biologics, and Medical Devices, ASQ Quality Press, 2nd edn., 2003.
69. www.gpoaccess.gov/cfr – Code of Federal regulations
70. http://grants.nih.gov/grants/olaw/references/outline.htm – Animal care guidelines
71. www.fda.gov/cdrh/qsr/contnt.html – Devices: quality systems regulations
72. www.fda.gov/cdrh/ode/ot476.html – Clinical trials for devices
73. www.fda.gov/cdrh/oivd/guidance/1549.html – Clinical studies for diagnostics
74. www.fda.gov/oc/ohrt/irbs/drugsbiologics.html#study – Clinical studies for drugs (biologics)
75. http://en.wikipedia.org/wiki/Critical_path_method – Product development critical path
76. www.iso.ch – Quality certification standards (ISO)
77. Beck, J. M. and Vale, A. Drug and Medical Device Product Liability Deskbook, Law Journal Press, 2004.
78. Coenraads, J., Van Broekhoren, B., Hartmann, S., Tander, H., and, Veldkamp, M. The CE Mark: Understanding the Medical Device Directive, Paton Press, ringbound edn., 1997.
79. Harnack, G. Mastering and Managing the FDA Maze: Medical Device Overview: A Training and Management Desk Reference for Manufacturers Regulated by the Food and Drug Administration, ASQ Quality Press, 1999.
80. Licinio, J. (ed.). The Pharmacogenomics Journal, Nature Publishing Group.
81. Pines, W.L. (ed.). How to Work With the FDA, Food and Drug Law Institute, 2nd edn., 2003.
82. Pisano, D. and Mantus, D. (eds.). FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices and Biologics, CRC Press, 2004.
83. Trautman, K. A. (compiler). The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices, ASQ Quality Press, 1996.
84. www.fda.gov/cdrh/qsr/contnt.html – Quality systems regulations for devices
85. www.raps.org – Regulatory Affairs Professionals Society of America
86. www.pharmweb.net/pwmirror/pwk/pharmwebk.html – A list of foreign regulatory bodies and links to their websites
87. www.mhra.gov.uk/– UK: MHRA (Medicines and Healthcare products Regulatory Agency, UK)
88. www.emea.europa.eu/– EMEA: The European Medicines Agency
89. www.tga.gov.au/– Australia: Therapeutics Goods Administration
90. www.hc-sc.gc.ca/index_e.html – Health Canada
91. www.mhlw.go.jp/english/index.html – Japan: Ministry of Health and Welfare
92. Abboud, L. and Hensley, S. Factory shift: new prescription for drug makers, The Wall Street Journal, (Eastern edn.), September 3, p. A1, 2003.
93. Bhatia, S. Microfabrication in Tissue Engineering and Bioartificial Organs (Microsystems), Springer, 1999.
94. Guarino, R. (ed.). New Drug Approval Process, Accelerating Global Registrations, Informa Healthcare, 4th edn., 2004.
95. Levin, M. (ed.). Pharmaceutical Process Scale-Up, Informa Healthcare, 1st edn., 2001.
96. Shuler, M. L. and Kargi, F. Bioprocess Engineering: Basic Concepts, Prentice Hall, 2nd edn., 2001.
97. Signore, A. and Jacobs, T. (ed.). Good Design Practices for GMP Pharmaceutical Facilities, Informa Healthcare, 2005.
98. Vogel, H. C. and Todaro, C. C. Fermentation and Biochemical Engineering Handbook: Principles, Process Design, and Equipment, Noyes Publications, 2nd edn., 1996.
99. Willig, S. (ed.). Good Manufacturing Practices for Pharmaceuticals: A Plan for Total Quality Control from Manufacturer, Informa Healthcare, 5th edn., 2000.
100. http://ts.nist.gov/Standards/Conformity/stdpmr.cfm – Standards – ABCs of standards in the USA
101. www.iso.org/iso/en/aboutiso/introduction/index.html – ISO website
102. www.fda.gov/cder/guidance/5882fnl.pdf – Clean rooms
103. www.fda.gov/cder/guidance/pv.htm – Process validation guidance
104. www.ispe.org – International society for technical professionals in the healthcare manufacturing industry
105. Bingefors, K., Pashos, C. L., Dix Smith, M., et al.Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2003.
106. Campbell, J. J, Understanding Pharma, Pharmaceutical Institute, 2005.
107. De Navas-Walt, C., Proctor, B. D., and Lee, C. H. Income, Poverty, and Health Insurance in the United States: 2005, US Census Bureau, Current Population Reports, P60-231, US Government Printing Office, 2006.
108. Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., and Stoddart, G. L. Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, 3rd edn., 2005.
109. Folland, S., Goodman, A. C., and Stano, M. The Economics of Health and Health Care, Prentice Hall, 4th edn., 2003.
110. Folland, S., Goodman, A., and Stano, M. (eds.). Economics of Health and Health Care, Prentice Hall, 2007.
111. Ohsfeldt, R.L. and Schneider, J. E. The Business of Health: The Role of Competition, Markets, and Regulation, AEI Press, 2006.
112. Phelps, C. E. Health Economics, Addison-Wesley, 3rd edn., 2003.
113. Walley, T., Haycox, A., and Boland, A. Pharmacoeconomics, Churchill Livingstone, 2004.
114. www.cms.gov – CMS Centers for Medicaid and Medicare Services
115. www.medpac.gov – MedPAC – advise Congress on Medicare (summary documents on Medicare processes; look under “other publications” link)
116. www.cms.hhs.gov/mcd/search.asp – Medicare coverage database (search for national and local coverage decisions)
117. www.cms.hhs.gov/MedHCPCSGenInfo/– HCPCS codes at CMS
118. www.ama-assn.org/ama/pub/category/3882.html – How a new CPT code is created
119. www.cms.hhs.gov/apps/acronyms/– Useful list of acronyms used in healthcare and by CMS
120. www.hrsa.gov/opa/glossary.htm – Glossary for drug pricing terms
121. www.cms.hhs.gov/HospitalOutpatientPPS/– Outpatient Prospective Payment system at Medicare
122. www.cms.hhs.gov/PhysicianFeeSched/– Medicare physician fee schedule
123. www.kff.org – Kaiser Family Foundation
124. www.upenn.edu/ldi – Leonard Davis Institute of Health Economics
125. www.nber.org – National Bureau of Economic Research (has many working papers on healthrelated topics)
126. www.nhs.uk/– National Health Service (United Kingdom)
127. www.cdc.gov/nchs/– National Center for Health Statistics (USA)
128. www.who.int/whosis/– WHO (World Health Organization) statistical information system